Skip to main content
HANGZHOU AGS MEDTECH CO.,LTD logo

HANGZHOU AGS MEDTECH CO.,LTD — Investor Relations & Filings

Ticker · 688581 ISIN · CNE100005ZF0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2023-12-29 AGM Information
Country CN China
Listing Shanghai Stock Exchange 688581

About HANGZHOU AGS MEDTECH CO.,LTD

http://www.bioags.com/en/index.aspx

Hangzhou AGS MedTech Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical instruments, primarily focusing on endoscopic accessories. The product portfolio encompasses a comprehensive range of disposable devices for gastrointestinal and respiratory interventions, including biopsy forceps, hemoclips, injection needles, polypectomy snares, and guide wires. The company integrates advanced manufacturing processes with rigorous quality management systems, adhering to international standards such as ISO 13485, CE, and FDA. By providing high-precision diagnostic and therapeutic tools, the organization supports clinical procedures in gastroenterology and pulmonology. Its technical expertise facilitates the delivery of reliable solutions aimed at improving procedural outcomes and patient safety in global healthcare markets.

Recent filings

Filing Released Lang Actions
2024年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2024 年第一次临时股东大会会议资料" which translates to "2024 First Extraordinary General Meeting (EGM) Meeting Materials". It contains detailed meeting agenda, voting procedures, proposals for changes in company registration address, amendments to the Articles of Association, governance system revisions, and election of supervisors. The content is typical of materials prepared and distributed for a shareholders' meeting, including detailed explanations of proposals to be voted on. There is no indication that this is a report of the meeting results or a summary announcement. The document is comprehensive and lengthy (15,000 characters), consistent with meeting materials rather than a brief announcement or voting results. Therefore, this document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting.
2023-12-29 Chinese
安杰思关于召开2024年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2024 first extraordinary general meeting of shareholders (临时股东大会) for Hangzhou Anjiesi Medical Technology Co., Ltd. It includes information about the meeting date, voting methods, agenda items, registration procedures, and proxy forms. There is no financial data, earnings, or audit information presented. The document is not a report itself but a formal announcement and invitation to shareholders to attend and vote at the meeting. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2023-12-20 Chinese
安杰思对外投资管理制度
Governance Information Classification · 95% confidence The document is titled '对外投资管理制度' which translates to 'External Investment Management System' and details the internal control, approval procedures, management, financial management, and auditing related to the company's external investments. It is a policy or governance document outlining rules and procedures for investment activities, approvals, and oversight within the company. There are no financial statements, earnings data, or audit results presented. The document is not an announcement or a brief summary but a detailed internal governance policy. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-12-20 Chinese
安杰思募集资金管理办法
Governance Information Classification · 95% confidence The document is titled '募集资金管理办法' which translates to 'Fundraising Capital Management Measures' and details the management, storage, usage, supervision, and regulatory compliance related to the company's raised funds. It references regulatory laws and stock exchange requirements, focusing on the internal rules and procedures for managing raised capital. There is no indication that this is a financial report like an annual or interim report, nor is it an announcement of voting results or a call transcript. The document is a detailed governance and compliance manual related to capital raising and fund management. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices related to capital management.
2023-12-20 Chinese
安杰思信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed information disclosure system of a company, outlining the principles, types, and procedures of information disclosure, including references to annual reports, interim reports, quarterly reports, and temporary reports. It discusses regulatory compliance with Chinese securities laws and Shanghai Stock Exchange rules, and specifies the content and timing of various reports and disclosures. The document is a comprehensive governance and procedural manual related to corporate information disclosure rather than an actual financial report or announcement. It does not contain financial statements, earnings data, or specific event announcements but rather the rules and policies governing disclosures. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-12-20 Chinese
安杰思关于监事辞职暨补选监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company supervisor (监事) and the nomination of a new supervisor candidate. It includes details about the resignation, the legal basis for the resignation and replacement, and biographical information about the new candidate. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content clearly relates to changes in company governance personnel, specifically the supervisory board. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and focused on personnel changes, not a report or announcement of a report publication.
2023-12-20 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.